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Background: External small bowel fistulae (ESBF) are serious complications that represent a major
challenge for general surgeons. They are still associated with significant morbidity and mortality. This
article reviews the management of ESBF with emphasis on the treatment using sub-atmospheric pres-
sure as well a timing, strategies and techniques of reconstructive surgery.
Methods: Relevant articles from 1960 to 2010 were identified using various electronic databases to review
randomized controlled trials, prospective observational studies, retrospective studies and case reports
and highlight key references.
Conclusions: External small bowel fistulae require multidisciplinary management and multimodal
approacheswith a primary essential focus on early recognition and diminishment ofmortality factors such
as sepsis and malnutrition. In most cases, the initial treatment is conservative, including clinical and
nutritional recovery, output control and extensive local wound care. At this stage, the application of local
negative pressure is highlyeffective. This procedure also allows for a spontaneous closure inmany patients.
Other cases require careful consideration of surgical reconstruction, knowing that success rates are variable
and largely dependent on the patient’s condition as well as on local aspects of the lesion. Best surgical
results are obtained via intra-peritoneal access with extensive enterolysis, resection of the bowel segment
fromwhich the fistulae originate and direct abdominal wall closure.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Enterocutaneousfistulae (ECF) are associatedwith highmorbidity
and mortality and its management remains a difficult challenge. In
1960 Edmunds and co-workers reported a global mortality rate of
43% of 157 patients suffering ECFs.1 At present, most publications
show mortality rates ranging from 5% to 30%.2e4 Nonetheless, in
presence of coexisting aggravating factors like sepsis, malnutrition
and large abdominal wall defects the mortality rate rises and can
exceed 60%.5e7
The aim of this review is to outline the current status in the
management of postoperative ECF, which involves the small bowel.
Special emphasis is placed on the output control of conservativeainstein).
ciates Ltd. Published by Elsevier Lttreatment based on sub-atmospheric pressure, as well as strategies
and techniques of reconstructive surgery.
2. Methods
The bibliographical search was conducted using different electronic databases
(incl. PubMed, Embase, Scopus, Biosis Previews and Cochrane Library) with
keywords including [enterocutaneous fistula], [management of enterocutaneous
fistulae], [small bowel fistula], [sub-atmospheric pressure] and/or [vacuum assisted
closure]. Key citations of related topics from the past 50 years (1960e2010) were
scrutinized, and together with personal experience provide the basis for this review.
The literature covering information about diagnosis, management as well as
outcome of external small bowel fistulae (ESBF) was analyzed for methodological
quality, and data on surgical technique, mortality, morbidity, fistula closure and
recurrence were reviewed.
2.1. Definition and characterization
An enterocutaneous fistula is defined as an abnormal communication between
hollow viscera and the skin or abdominal wound.3 In order to identify its charac-
teristics, three main aspects must be considered: anatomy, aetiology and
pathophysiology.8d. All rights reserved.
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REVIEWConsidering the anatomical site of origin, jejunal as well as ileal fistulae can be
divided into two types: lateral, when the intestinal defect partially interrupts
visceral continuity, or terminal, when there is complete intestinal discontinuity.
Furthermore they are classified as superficial or deep fistulae depending on the
length of their tract (lower or higher than 2 cm), which in turn can be simple or
complex according to their shape.
The pathologic-anatomical features are an important guideline for the
management and prognosis. Frequently complicating attributes hinder or impede
spontaneous closure (Table 1).9e11
Most commonly (75e90%) ESBF develop as a postoperative complication of
abdominal surgery with an incidence of 0.5e1.5%. Less frequently (10e25%) they
occur as complication of chronic intestinal diseases such as Crohn’s disease, radia-
tion enteritis, malignancies, trauma or ischemia.5,12
Fistulae are further defined according to their output into low or high output
fistulae depending on whether their drainage is lower or higher than 500 ml/
24-hours.5 An important consequence of a high output enterocutaneous fistula is
a hydroelectrolyte imbalance that may lead to dehydration and metabolic disor-
ders.13 The loss of nutrients along with hypercatabolism due to sepsis and the
reduceddietary intake leads to furthermalnutrition. The impact of these events leads
to ileus prolongation, increased likelihood of wound dehiscence, muscle atrophy,
complications related to hospitalization and, consequently, increased mortality.13
Intestinal fluid emanating from the ESBF irritates the abdominal wall, causes
chemical dermatitis which in turn renders the musculoaponeurotic tissue more
susceptible to infection. Once a severe infection of this tissue has established
appearance of sepsis is the rule rather than the exception. Nevertheless, sepsis can
also originate from extra-intestinal sources such as intravenous catheters, pulmo-
nary and urinary tract. This is important because sepsis constitutes the principal
independent predictor of mortality.
2.2. Diagnosis
A detailed evaluation of the patient’s clinical condition and the fistula charac-
teristics are necessary for further decisions regarding the treatment. Special atten-
tion should be given to the primary underlying pathology (e.g. cancer) and previous
surgical protocols as well as preexisting images should be reevaluated.
While the assessment of the nutritional status is an essential diagnostic
measure, there is no consensus on the best method for its accurate evaluation. In the
past, a patient was considered severely malnourished if the plasma albumin
concentration was less than 3 g/dl and the weight loss greater than 20% of its
theoretical value.13 A considerable body of evidence including an assessment using
dual-energy X-ray absorptiometry, has demonstrated that decreased serum albumin
does not serve as an indicator of isolated protein-energy malnutrition since it
neither correlates with the lean mass, appendicular skeletal muscle mass, nor body
cell mass indexes.14 However, it could be shown that serum albumin functions as
a predictor for greater risk of mortality, morbidity, length of stay and complication
rate.14,15 Fluid imbalance influences anthropometricmeasurements, andmany of the
classical biologic parameters including prealbumin and transferrin, are affected by
non-nutritional factors such as inflammation and are thus inappropriate indicators
in ESBF patients, who often suffer from fistula-associated inflammatory complica-
tions or chronic diseases. Along with other authors we suggest, that until new
analytical approaches with surrogate markers to assay malnutrition become avail-
able, a combination of clinical and biochemical parameters along with subjective
criteria should be used to estimate the presence of malnutrition in order to design
adequate delivery of nutrients and evaluate the response to treatment.16e18 The
presence of sepsis should in first place call attention to an abdominal focus. In the
absence of evidence of intra-abdominal infection, it should not be overlooked that
the source might also derive from an extra-abdominal origin. If, after thorough
diagnostic inspection, a cause can still not be determined, the possibility of intra-
abdominal interloop abscesses should be reconsidered. Intra-abdominal abscesses
were found in 50% of 203 patients undergoing definitive surgery of ECF, which had
gone undiagnosed in previous computational imaging.19 Abscesses may be multiple,
small and located in an abdomen that may entail significant anatomical changes as
consequence of preceding surgery. Given that multiple prior surgeries may decrease
the effectiveness of a CT scan, laparotomy may also be indicated.Table 1
Anatomic factors which influence the possibility of spontaneous closure.
Favourable Unfavourable
Deep fistula Superficial fistula
No adjacent abscess Adjacent abscess
Free distal passage Distal occlusion
Healthy adjacent intestine Diseased adjacent intestine
Preserved intestinal continuity Intestinal dehiscence
Defect minor than 1 cm Defect major than 1 cm
Single fistula Multiple fistulae
Intact abdominal wall Abdominal wall defect2.3. Imaging
Ultrasound andCTscan should be initially used to evaluatewhether the intestinal
fluid passing through the fistula is leaking completely out of the body or remains
partially retained in the abdominal cavity, either freely or forming abscess.
Fistulography allows for a better understanding of anatomical characteristics,
especially in the case of deep fistulae. By injection of a hydrosoluble contrast agent
through the external orifice, the paths to the intestinal tract can be visualized
providing information about its length, shape, eventual intermediate cavities and
origin site. Distal obstructions and foreign bodies can also be detected. Small bowel
tract contrast, barium enema, and endoscopy studies offer complementary infor-
mation revealing the status of the remainder of the digestive tract.20,21
2.4. Management guideline
While variations in treatment may be appropriate according to the needs of
individual patients, guideline of ESBF treatment can be summarized in a four-stage
protocol adapted from Chapman that describes, with some modifications, possible
therapeutic procedures alternatively [Fig. 1].22
Stage0dDecision.Having identified thefistulawith its diagnostic characteristics,
the team should decide on whether to follow a conservative treatment or an urgent
surgical procedure. The conservative pathmay lead to spontaneous fistula closure or
aim to stabilize the patient in order to face definitive surgery. Surgery is initially
necessary in cases of acute abdomen such as septic peritonitis, bowel obstruction or
underlying concomitant urgent surgical pathology. Surgical treatmentmayalso be of
initial choice in patients with early postoperative fistulae in good clinical condition.
Stage 1dStabilization. The stabilization phase requires the re-establishment of
the electrolytic balance, circulating volume. Another goal is to reduce fistula output
to less than 500 ml/day. Intra-abdominal infections should be ruled out or, when
detected, adequately drained.
Stage 2dImprovement. The stabilized patient is better able to receive and to
incorporate nutritional support. Contrast studies during the progress will indicate
fistula anatomy to anticipate the possibility of spontaneous closure or to help for
further eventual changes in treatment strategies e.g. reconstructive surgery.
Stage 3dResolution. In the absence of wound healing, visibly by granulation,
a spontaneous closure may not occur and reconstructive surgery may be required.
2.5. Conservative treatment and application of local sub-atmospheric pressure
Since the 1960s there has been a general consensus that surgery in patients with
sepsis, malnutrition and/or hydroelectrolytic disorders bear high risks of fistula
recurrence, morbidity and mortality.1,22 Therefore, conservative treatment, con-
sisting of hydroelectrolyte imbalance correction, treatment of sepsis and nutritional
support, constitutes the standard initial approach to most ECFs. Adjunctive surgical
measures include appropriate output control and wound care.
Once sepsis has been successfully eradicated it is possible to optimize the
nutritional support. Preferentially, patients should receive enteral nutrition. It
promotes intestinal integrity, prevents mucosal atrophy, bacterial translocation and
consequently reduces the chance of sepsis reappearance. However, parenteral
support may initially be necessary until a transition to total enteral nutrition is
possible. Evidence shows that fistula output, mortality and spontaneous closure areReconstructive Surgery 
Fistula Resection 
Intestinal Reconstruction 
Stage 2: Improvement 
Nutritional Support 
Local Wound Care 
Stage 3: Resolution
Spontaneous Closure Operative Closure 
Fig. 1. ESBF Treatment Guide. Schematic diagram of practical therapeutic ESBF
management.
Fig. 2. Sub-atmospheric Pressure (Vacuum-Compaction) System. Illustration of the
technical device applying sub-atomospheric pressure.
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Answering this question exceeds the purpose of this manuscript which is why we
would like to recommend the following literature, where this relevant aspect are
addressed in its necessary extent: Evenson & Fischer, 2006; Chintapatla & Scott,
2002; Osborn & Fischer, 2009; Slater, 2009.3,24e26
During the last twenty years severalmethods havebeen developed in order to try
to diminish fistula leakage. These methods include biological fibrin glue, porcine
small intestine submucosa and fast hardening amino acid solution, among others.
Althoughfirst results seemencouraging, their efficacyhas still yet to beproven.9,27e29
Consolidated therapeutic approaches to reduce the enteric fluid loss are
suppression of oral intake, administration of total parenteral nutrition (TPN) and
exocrine-suppressing somatostatin analogues, which inhibit the release of
numerous gut hormones and decrease splanchnic and portal flow.30,31 Initial
problems with somatostatin treatment, more precisely, the short plasma half-life
and the “bouncing effect’’, which by discontinuation led to undesired increase of
insulin, glucagon and growth-hormone secretion, have been overcome by the long-
acting somatostatin analogue octreotide.32 It has been widely used in the manage-
ment of ESBFs for now two decades. However, enthusiasm for its use recently
decreased since results of a randomized double-blind placebo-controlled trial have
become available which demonstrated that although octreotide is able to diminish
output and time of closure in some cases, it fails to demonstrate significant increase
in spontaneous closures or a decrease in mortality.33Fig. 3. Compaction Chamber. A) Karaya paste is spread on the skin of the abdomen. The
embedded and finally sealed with polythene film. B) Application of sub-atmospheric pressu
wound edges together.In 1989, Chariker et al. reported on the first series of patients with ECFs treated
with sub-atmospheric pressure.34 In 1992, Fernandez et al. developed a technique
that used compactionwithhigh sub-atmospheric pressure, values exceeding 400mm
Hg, in order to compact and occlude intestinal communications with the skin [Figs. 2
and 3].11 There remains controversy as to the optimal values of sub-atmospheric
pressure for the treatment. Several groups administered sub-atmospheric pressure
values between 80 and 120 mm Hg.35,36 These low values are based on first
approaches carried out by Russian scientists, who treated chronic wounds (not ECF)
with sub-atmospheric pressure to obtain tissue healing. This effect was not repro-
duced with lower levels of pressure. Also other groups concluded that high sub-
atmospheric pressure is needed to achieve complete fistula closure.11,37,38 Results
obtained by mathematical modelling, where a numerical relationship between the
fistula compressibility and closure time of enterocutaneous fistulae was established,
justify the debate on pressure values.39 The model simulations revealed that the
magnitudeof pressurewhich needs tobe exposed in order to achievefistula closure is
significantly determined by the tissue elasticity and consequential compressibility of
the fistula. Tissue elasticity in turn is closely related to the intestinal wall structure
(e.g. collagen content) and thickness including villi height, crypt depth, and the
thickness of mucosa, submucosa and muscle. Since different pathologies (inflam-
mation, cancer, fasting etc.) and different stages of wound healing process generate
changes in the structure of the intestine, it is to be expected that the biomechanical
properties change aswell.40 Themodel predicted that fistulaewith a higher elasticity
index are associated with a higher success rate of fistula closure.39
Different authors describe favourable outcomes when applying topical sub-
atmospheric pressure. It has been helpful in cases where regular conservative
treatmentwas ineffective aswell as in improving the patient’s nutritional status prior
to surgery.41 The technique offers various benefits; by shielding the skin from the
corrosive gut secretions, it helps to maintain skin integrity around the fistula and
lowers the frequency of requirements in dressing changes. The sub-atmospheric
pressure in the compaction chamber undermines bacterial growth and supports
absorption of superficial abscesses yet encourages angiogenesis with ensuing gran-
ulation. The output reduction facilitates the balance of fluid and electrolyte and
accelerates the initiation of oral food intake. Also, the system may have long silicon
drains or a portable pump allowing the patient to move which benefits to the
recovery process and has positive psychological impact.
Thus, the vacuummethod offers different types of results: curative in the case of
achievement of spontaneous closure, temporizer when the patient’s clinical
condition improves enough to afford surgery for reconstruction or palliative offering
a better life quality in advanced neoplastic pathologies. Additionally, treatment with
sub-atmospheric pressure does not require sophisticated resources and seems to
have a superior cost-benefit relationship when compared with treatments based on
TPN alone or in combination with octreotide.34
While in our experience the application of local sub-atmospheric pressure
seems promising, there is not enough pooled data available to draw definitive
conclusions regarding its outcome measures. Attempts thus far to statistically
evaluate fistula closure with or without the use of sub-atmospheric pressure
(Student t test, N.S., mean standard error), studies hitherto, listed in Table 2, showno
significant difference between the two treatments (7.8 3.2 with as opposed to
28.914.5 without its application). It also seems as if topical sub-atmospheric
pressure does not affect mortality rates (16.0 3.7 as opposed to 14.8 2.6 without
its use). Yet we think that this would be a wrong conclusion, since the studies differ
in a variety of important parameters which strongly influence the final results such
as the length of the fistula path, the volume of output and the presence or absence of
abdominal wall defects. Paying closer attention, sub-atmospheric pressure was
mostly applied where conventional treatment has failed, and it is consequently not
unbiased to compare the outcome of one study with another.paste is then covered with a coat of polymer fibers where the evacuation tubes are
re leads to polymer contraction. This causes tension on the fistula orifice and forces the
Table 2
Conservative treatment outcomes and study parameters.
Authors Levy
et al.7
Campos
et al.5
Li
et al.4
Hollington
et al.2
Martinez
et al.43
Vischers
et al.16
Fernandez
et al.11
Hyon
et al.56
Dionigi
et al 48
Wainstein
et al.38
N 335 188 1168 277 174 135 14 21 19 91
Type of fistula ESBF ECF ECF ECF ECF ECF ECF ECF ECF ECF
Sub-atmospheric
pressure
No No No No No No Yes Yes Yes Yes
Postoperative origin Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Non-surgical origin Yes Yes Yes Yes No Yes No No No No
Abdominal wall defect No n.m. n.m. Yes n.m. Yes Yes Yes Yes Yes
Spontaneous closure (%) 97 (29) 59 (31) 420 (36) 55 (20) 65 (37) 21 (16) 11 (79) 5 (23) 0 (0) 46 (42)
Mortality (%) 65 (25) 58 (31) 66 (6) 30 (11) 23 (13) 13 (10) 1 (7) 3 (14) 4 (21) 7 (17)
n.m. ¼ not mentioned.
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REVIEW2.6. Reconstructive surgery
Despite best efforts, there are a 30e75% of patients with ESBF requiring surgery
for its definite repair.16,23,42,43 In such cases, the aim of further treatment is to obtain
fistula closure by surgical means.
2.6.1. Timing of surgery
The right timing of the surgical procedure remains controversial. For a long time
itwas convention towait 4e6weeks for a spontaneous resolution and then, in case of
persistence, to proceedwith reconstructive surgery.1,36 First, it should be pointed out
that fistula closure has been achieved in some cases, after this time period, with the
assistance of innovative treatments such as sub-atmospheric pressure.36,38,44
Second, the previously defined time span, usually, is not enough to obtain an
adequate clinical and nutritional condition in order to perform complex recon-
structive surgery. Infectious complications such as sepsis from central line catheter
and pulmonary infection may delay nutritional recovery, as well as surgical oppor-
tunity. Lynch et al. conclude in favour of delaying surgery for at least 12 weeks to
decrease chances of recurrence, though their statistical analysis of timing in relation
to fistula recurrence did not demonstrate a significant difference.19 Many authors
share his opinion and caution against early reoperation. They reason that dissection
in a dense peritoneal reaction is prone to cause hemorrhages and bears high fistula
recurrence rates.45 In particular after multiple laparotomies for severe intra-
abdominal infection, awaiting consolidation and the formation of neoperitoneum
seems comprehensible. Signs, such as the return of a soft abdomen with residual
induration limited to the perifistula region, as well as prolapsing of the fistulating
bowel could be indicators of an adequate moment to approach surgery again.2 The
time spectrum of the latest studies ranges from 2 to 11months.16,46 Quite the reverse
is the conclusion drawn by Brenner and colleagues when specifying the issue of
timing and recurrence of ECFafter operative repair in their recent study. In contrast to
the above authors, her results indicate a significant increase of recurrence if repair is
delayed past 36 weeks. Despite employing meticulous statistical analysis, also exact
interpretations of these results are limited (due to selection of patients) and lack
specific protocols.47 It appears as though prospective studies are needed that specify
timing of operation in a more detailed manner to identify which factors are
responsible for increasing the risk for ECF recurrence. Meanwhilewe believe that the
timing of surgery should be considered on the basis of day-to-day patient charac-
teristics instead of fixating a set time period as has been proposed elsewhere.16
2.6.2. Strategy and technique
The surgical procedure involves three main steps: access, intestinal treatment
and abdominal wall closure. The access to the peritoneal cavity needs be wisely
chosen. The incision must anticipate potential necessity for abdominal wall recon-
struction with tissue of good vascular supply and provision of abdominal wall
structures with adequate strength to reduce the risk of wound disruption.42 The
abdomen may be accessed by a vertical midline above the previous incision, across
healthy tissue. Another possibility is to incise surrounding the fistula in order to
perform a resection en-bloc together with the surrounding granulation tissue and
the overlying skin.48 It is not advisable to execute various parallel incisions. Adding
new injury, they interfere with blood irrigation at the wound edges and become an
obstacle for the eventual ostomy exteriorization.8,49,50 The enterolysis should be
extensive, if possible from the duodenojejunal flexure to the ileocecal valve, in order
to obtain broad and clear vision of the anatomy, to reduce the possibility of
immediate postoperative obstruction and to adequately liberate the adherent bowel
from the abdominal wall. This will facilitate abdominal closure and drainage of small
abscesses, which otherwise could remain overlooked.3,42,51
The resection of the bowel segment containing the fistula should be reduced to
the minimum length which still allows the apposition of two intact and healthy
intestinal stumps. In presence of multiple lesions, it is essential to perform as few
anastomoses as possible with attention to the length of the residual intestine, since
in patients with previous resections there is the potential risk of short intestinesyndrome as a sequel, especially if there is no ileocecal valve.12,16 Current evidences
are still insufficient to clearly demonstrate superiority of a particular technique
concerning the types of anastomosis and mechanic sutures.19,47,52 Wedge repair and
bypass with fistula exclusion are alternatives that lead to suboptimal results and
should not be employed except in cases of extreme necessity, e.g. when unable to
mobilize the fistulized bowel segment.19,47,52 In these cases it should be considered
to protect the repair with a proximal stoma. Patients with ESBF frequently have
a serious wall defect, either due to multiple prior surgical interventions, open
abdomen or evisceration. An inadequate strategy during abdominal closure time
may increase the risk of fistula recurrence.51,53 In an attempt to minimize such
complication risk, primary abdominal wall closure has been shown to be the best
option, even with components separation techniques if necessary.51 Numerous
types of meshes have been developed to optimize the repair of abdominal wall
defects, which can be classified according to their pore size and composition of
material based on polymers (typically polypropylene, polyester, or expanded poly-
tetrafluoroethylene).54 They can be absorbable or non-absorbable. Non-absorbable
mesh ensures durable abdominal wall prosthesis. However, the application of a non-
absorbable mesh is associated with an increased risk of infection mainly in
contaminated abdominal wall. In many cases, often due to prior operations, there is
not sufficient omentumwhich can be interposed between mesh and bowel in order
to prevent that the implanted mesh damages exposed bowel.3,51 For this reason,
currently the use of absorbable mesh achieves generally higher approval.12,46 Yet,
despite advances, especially regarding their biomechanical resistance, mesh appli-
cation in general is still prone to complications such as the formation of adhesions,
small bowel obstruction and fistula recurrence.46
In recent years, new types of prostheses to optimize the treatment of large
abdominal wall defects have appeared. These meshes are composed of a core
component that provides non-absorbable biomechanic resistance and secondary
component designed to prevent bowel adhesions to the prosthesis. Biological
prostheses are allografts or heterografts that, specifically processed, lose their
cellular component and keep the absence of omentum serving this extracellular
matrix structure, or framework, for the infiltration of connective tissue whose
regeneration is sought. Efforts have been made with both types of meshes, the
benefits of rapid integration cell and at the same time have a cover to prevent
adhesions and intestinal fistulae.55 Nevertheless, for application in the contami-
nated open abdomen as with intestinal fistulae, experience to date has been limited
and yielded mixed results. Reconstructive surgery by means of musculocutaneous
flaps, using e.g. the tensor fasciae latae, is suited for a stable coverage of the
abdominal wall and has the advantage that it offers a good local blood supply that
provides protection against infections, possibly leading to fistula reopening.53 The
procedure is complicated, long-lasting and associated with considerable morbidity
at both the donor and the recipient sites and reoperations are common, which is
why it should be used as a last resort method in patients, where prosthetic repair is
contraindicated (e.g. infectious contamination).
2.6.3. Morbidity and mortality
Surgical reparation of an intestinal fistula is associated with high morbidity
(30e83%).10,42,46 The most frequent complications are: infection of surgical site,
respiratory complications and recurrence.46,48 The incidence of the latter is between
13 and 33% and the mortality rate between 9 and 30%. This may be related to wedge
repair without intestinal resection and the impossibility to achieve primary
abdominal wall closure, especially when viscera covering omentum is not feasible.
Both early recurrence and abdominal wall defects are significantly related to higher
mortality rates.6,12,46
3. Conclusions
Bearing in mind the referenced studies cited in the literature
and our own experience, the principles that should govern the
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REVIEWmanagement of small intestine external fistulae can be summa-
rized as follows:
1. Small bowel fistulae initially require aggressive treatment and
in most cases may be managed conservatively.
2. Mortality rates and recovery can be improved by early accurate
diagnosis and treatment of septic patients.
3. Adequate output control has a significant impact on clinical
and nutritional recovery. Here the topic application of sub-
atmospheric pressure to achieve vacuum assisted closure
seems to be promising.
4. Once the patient is stabilized, efforts must be made to optimize
nutritional recovery. Malnutrition hampers fistula closure and
any necessary reconstructive surgery involves a high risk of
recurrence.
5. Complicated and persistent fistulae require reconstructive
surgery, yet should only be attempted when feasible. The
timing of surgical intervention should be adapted to each
particular case depending on the clinical and nutritional state
along with the pathological and surgical history of the patient.
In recent years, a progress has been made in the management of
this complication. Improved diagnostic methods, better control and
treatment of sepsis, nutritional support and new resources for local
wound care have, to some extent, reduced concomitant mortality.
Nevertheless, due to not only substantial differences between
patients within one study but also inter-study variations in the
currently available data, it is difficult to draw definite conclusion on
their respective treatment effect. It seems, therefore, necessary that
multidisciplinary teams gather detailed information to be able to
collectively pool the data in order to reach firm conclusions.
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